| Ytd | -68.32% | |
| 1y | -87.26% |
| Open | 2.76 | Prev Close | 2.94 | Low | 2.58 | High | 3.10 | Mkt Cap | 2.18M |
| Vol | 1.29M | Avg Vol | 1.13M | EPS | -30.50 | P/E | N/A | Forward P/E | -1.01 |
| Beta | 1.93 | Short Ratio | 0.11 | Inst. Own | 5.37% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 4.35 | 200-d Avg | 8.21 | 1yr Est | 20.00 |
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announce